Categories: All postsAnalysts

Computer Modelling Group downgraded at Ventum

Ventum Capital Markets analyst Amr Ezzat downgraded Computer Modelling Group (Computer Modelling Group Stock Quote, Chart, News, Analysts, Financials TSXV:CMG) to “Neutral” from “Buy” on May 22, cutting his price target to $9.00 from $14.00 and warning that “we expect the stock to remain range-bound over the coming quarters.”

Reduced visibility and a softer outlook prompted Ezzat’s move.

He approached CMG’s Q4 fiscal 2025 cautiously, a view that proved justified as the company posted weaker-than-expected results. Revenue came in at $33.7-million and EBITDA at $10.5-million, falling short of both consensus estimates ($36.0-million and $11.8-million) and Ventum’s more conservative forecasts ($34.8-million and $11.2-million).

More concerning than the earnings miss, Ezzat noted, was the decline in disclosure.

“Segment-level details – elements that had become standard in CMG’s MD&A since it began making acquisitions – were absent. While the President’s letter reaffirmed the outperformance of the acquired businesses relative to legacy solutions, the lack of granularity makes it more difficult to track the pace and effectiveness of that transition.”

Ezzat believes the operational weakness is multi-faceted and more pronounced than expected.

“The U.S. CCS market has cooled, with many tax-incentive-driven feasibility studies (under the IRA) not renewing,” he said. “Smaller operators are under pressure, and customers are increasingly rationalizing software spend across vendors. Meanwhile, professional services revenue is expected to decline by $6–7M in F2026, simulation growth visibility has deteriorated faster than anticipated, and while Seismic is a bright spot, it still represents a smaller portion of the mix.”

The analyst expects the company to generate $44.0-million in Adjusted EBITDA on $129.4-million in revenue for fiscal 2025. He projects those figures will dip slightly to $42.5-million in EBITDA on $126.2-million in revenue in 2026, before rebounding in 2027 to $47.2-million in EBITDA on $132.6-million in revenue.

Ezzat said the stock reaction likely reflects more than just the earnings miss; it also signals investor concern over reduced disclosure and a weakening simulation outlook. With Q1 and Q2 expected to be seasonally softer and recurring revenue needing to grow 7–8% just to offset declining services revenue, he believes the stock will likely remain range-bound in the near term.

-30-

Tagged with: CMG
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Hut 8 stock: Buy, Sell or Hold?

Roth Capital Partners analyst Bryan Baratian maintained his “Buy” rating and US$108.00 target on Hut 8 (Hut 8 Stock Quote,… [Read More]

7 hours ago

This investor explains why he loves Topicus stock

Baskin Wealth Management president and chief investment officer Barry Schwartz named Topicus.com (Topicus.com Stock Quote, Chart, News, Analysts, Financials TSX:TOI)… [Read More]

7 hours ago

RNA stock: time to buy?

On Oct. 29 Roth Capital Partners analyst Boobalan Pachaiyappan maintained his “Buy” rating and US$15.00 target on Atrium Therapeutics (Atrium… [Read More]

7 hours ago

TD raises price target on Coveo Solutions

TD Cowen analyst David Kwan raised his target on Coveo Solutions (Coveo Solutions Stock Quote, Chart, News, Analysts, Financials TSX:CVO)… [Read More]

11 hours ago

Electrovaya has an upside of 143%, this analyst says

Roth Capital Partners analyst Craig Irwin maintained his “Buy” rating and US$14.00 target on Electrovaya (Electrovaya Stock Quote, Chart, News,… [Read More]

13 hours ago

Analyst raises his price target on Kinaxis to $225.00

Stifel analyst Suthan Sukumar raised his target on Kinaxis (Kinaxis Stock Quote, Chart, News, Analysts, Financials:TSX:KXS) to $225.00 from $200.00,… [Read More]

13 hours ago